Latest News

  • RESEARCH

    27 Feb 2026

    Can AI Crack the Code on Fibrosis?

  • INNOVATION

    25 Feb 2026

    AI Unlocks the Secret to Cell Entry

  • PARTNERSHIPS

    24 Feb 2026

    U.S. Peptide Groups Form GMP Alliance

  • INVESTMENT

    23 Feb 2026

    $305mn Bet on Peptides Signals Shift in Cancer

AI-Designed Peptide Enters Late-Stage Infection Trial

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections 

Close-up of Her-2 test tube labeled sample in gloved hand

RESEARCH

27 Feb 2026

Can AI Crack the Code on Fibrosis?

Animate Biosciences launches AnimateIQ, with early data showing reduced inflammation and fibrosis markers in lab and animal studies

Automated laboratory instrument inside biotech research facility under purple lighting

INNOVATION

25 Feb 2026

AI Unlocks the Secret to Cell Entry

1910 unveils PEGASUS™, an AI platform designed to help macrocyclic drugs cross cell membranes and speed early discovery

Pharmaceutical technician operating GMP tablet production equipment

PARTNERSHIPS

24 Feb 2026

U.S. Peptide Groups Form GMP Alliance

Lifecore and PolyPeptide link domestic API and fill-finish capacity as demand for peptide drugs grows

Biogen logo on exterior sign outside modern office building

INVESTMENT

23 Feb 2026

$305mn Bet on Peptides Signals Shift in Cancer

Parabilis raises funding from RA Capital, Fidelity and Janus to advance intracellular peptide drugs into late-stage trials

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

AI-Designed Peptide Enters Late-Stage Infection Trial

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections 

Injectable treatment pen and packaging used for metabolic therapy

MARKET TRENDS

19 Feb 2026

GLP-1 Makers Test New Routes to Patients

Drugmakers expand cash-pay and digital channels as competition shifts from clinical results to access and demand control

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.